Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 1999 1(1):61-68; DOI:10.1215/15228517-1-1-61
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paleologos, N. A.
Right arrow Articles by Cairncross, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Symposium Genetic Classification and Treatment of Malignant Gliomas and Oligodendrogliomas

Treatment of oligodendroglioma: An update

Nina A. Paleologos1 and J. Gregory Cairncross

Evanston Northwestern Healthcare, Evanston, IL 60201 [N.A.P.]; London Regional Cancer Centre, London, Ontario, Canada N6A 4L6 [J.G.C.]

1 Address correspondence and reprint requests to Nina A. Paleologos, MD, Division of Neurology, Evanston Hosptial, 2650 Ridge Avenue, Evanston, IL 60201.

Abstract

Oligodendrogliomas are rare primary brain tumors. Significant attention has recently been focused on these interesting neoplasms because of their unique chemosensitivity and the durability of some of these responses. Surgery and radiation continue to play important roles in the treatment of oliogodendrogliomas. Molecular genetic analyses have given new insight into the allelic deletions that distinguish these tumors and their progression from indolent to more aggressive forms. In the future, molecular genetic analysis may guide therapeutic decisions concerning patients with oligodendroglioma and may help us learn more about how to best treat other malignant brain neoplasms.

References

Bailey, P., and Bucy, P.C. (1929) Oligodendrogliomas of the brain. J. Pathol. 32,735 -751.[CrossRef]

Bailey, P., and Cushing, H. (1926) Tumors of the Glioma Group. Philadelphia: Lippincott.

Bailey, P., and Hiller, G. (1924) The interstitial tissues of central nervous system: A review. J. Nerv. Ment. Dis. 337-361.

Brown, M.T., Cairncross, J.G., Vick, N.A., Mcdonald, D.R., Friedman, H.S., Dropcho, E.J., Schold, S.C., Jr.(1990) Differential response of recurrent oligodendrogliomas vs astrocytomas to intravenous (iv) melphalan. Neurology 40 (Suppl. 1), 397-398. (Abstract)

Bullard, D.E., Rawlings, C.E., III, Phillips, B., Cox, E.B., Schold, S.C., Jr., Burger, P., and Halperin, E.C. (1987) Oligodendroglioma: An analysis of the value of radiation therapy. Cancer 60,2179 -2188.[CrossRef][Web of Science][Medline]

Cairncross, J.G., and Eisenhauer, E.A. (1995) Response and control: Lessons from oligodendroglioma. J. Clin. Oncol. 13,2475 -2476. (Letter)[Free Full Text]

Cairncross, J.G., and Macdonald, D.R. (1988) Successful chemotherapy for recurrent malignant oligodendroglioma. Ann. Neurol. 23,360 -364.[CrossRef][Web of Science][Medline]

Cairncross, G., MacDonald, D., Ludwin, S., Lee, D., Cascino, T., Buckner, J., Fulton, D., Dropcho, E., Stewart, D., and Schold, C., Jr. (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 12,2013 -2021.[Abstract/Free Full Text]

Cairncross, G., Swinnen, L., Stiff, P., Rosenfeld, S., Vaughan, W., Paleologos, N., Kaminer, L., DeAngelis, L., Nimer, S., Dropcho, E., Peterson, K., Forsyth, P., Stewart, D., Weaver, S., Lieberman, F., Macdonald, D., Ramsay, D., Smith, A. (1997) High-dose thiotepa with hematopoietic reconstitution (deferring radiation) for newly diagnosed aggressive oligodendroglioma. ASCO 16, 388a. (Abstract)

Cairncross, J.G., Ueki, K., Zlatesou, M.C., Lisle, D.K., Finkelstein, D.M., Hammond, R.R., Silver, J.S., Stark, P.C., Macdonald, D.R., Ino, Y., Ramsay, D.A., and Louis, D.N. (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 90,1473 -1479[Abstract/Free Full Text]

. Celli, P., Nofrone, I., Palma, L., Cantore, G., and Fortuna, A. (1994) Cerebral oligodendroglioma: Prognostic factors and life history. Neurosurgery 35,1018 -1035.[Web of Science][Medline]

Chen, R., Macdonald, D.R., and Ramsay, D.A. (1995) Primary diffuse leptomeningeal oligodendroglioma. Case report. J. Neurosurgery 83,724 -728.[Web of Science][Medline]

Dolinskas, C.A., and Simeone, F.A. (1987) CT characteristics of intraventricular oligodendrogliomas. Am. J. Neuroradiol. 8,1077 -1082.[Abstract]

Fortuna, A., Celli, P., and Palma, L. (1980) Oligodendroglioma of the spinal cord. Acta. Neurochir. 52,305 -329.

Frosina, G., Rossi, G., Arena, G., Gentile, S.L., Bruzzone, E., and Abbondandolo, A. (1990) O6-alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett. 55,153 -158.[CrossRef][Web of Science][Medline]

Gannett, D.E., Wisbeck, W.M., Silbergeld, D.L., and Berger, M.S. (1994) The role of postoperative irradiation in the treatment of oligodendroglioma. Int. J. Radiat. Oncol. Biol. Physics 30,567 -573.[Web of Science][Medline]

Garza-Mercado, R., Campa, H., and Grajeda, J. (1987) Primary oligodendroglioma of the septum pellucidum. Neurosurgery 21,78 -80.[Web of Science][Medline]

Glass, J., Hochberg, F.H., Gruber, M.L., Louis, D.N., Smith, D., and Rattner, B. (1992) The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J. Neurosurg. 76,741 -745.[Web of Science][Medline]

Kallio, M. (1990) Therapy and survival of adult patients with intracranial glioma in a defined population. Acta. Neurol. Scand. 81,541 -549.[Web of Science][Medline]

Kedar, A., Maria, B.L., Graham-Pole, J., Ringdahl, D.M., Quislng, R.G., Mickle, J.P., Mendenhall, N.P., Marcus, R.B., Jr., and Gross, S. (1994) High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors. Med. Pediatr. Oncol. 23,428 -436.[Web of Science][Medline]

Kros, J.M., Lie, S-T., and Stefanko, S.Z. (1994a) Familial occurrence of polymorphous oligodendroglioma. Neurosurgery 34,732 -736.[Web of Science][Medline]

Kros, J.M., Pieterman, H., Van Eden, C.G., and Avezaat, C.J. (1994b) Oligodendroglioma: The Rotterdam-Dijkzigt experience. Neurosurgery 34,959 -966.[Web of Science][Medline]

Kyritsis, A.P., Yung, W.K.A., Bruner, J., Gleason, M.J., and Levin, V.A. (1993) The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32,365 -371.[Web of Science][Medline]

Lee, S.K., and Kelly, D.L., Jr. (1990) Primary oligodendroglioma of the lateral ventricle. South. Med. J. 83,254 -255.[Web of Science][Medline]

Lee, Y-Y., and Tassel, P. (1989) Intracranial oligodendrogliomas: Imaging findings in 35 untreated cases. Am. J. Roentgenol. 152,361 -369.[Abstract/Free Full Text]

Leighton, C., Fisher, B., Bauman, G., Depiero, S., Stitt, L., MacDonald, D., and Cairncross, G. (1997) Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation. J. Clin. Oncol. 15,1294 -1301.[Abstract/Free Full Text]

Levin, V.A., Edwards, M.S., Wright, D.C., Seager, M.L., Schimberg, T.P., Townsend, J.J., and Wilson, C.B. (1980) Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat. Rep. 64,237 -244.[Web of Science][Medline]

Lindegaard, K-F., Mørk, S.J., Eide, G.E., Halvorsen, T.B., Hatlevoll, R., Solgaard, T., Dahl, O., and Ganz, J. (1987) Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J. Neurosurg. 67,224 -230.[Web of Science][Medline]

Ludwig, C.L., Smith, M.T., Godfrey, A.D., and Armbrustmacher, V.W. (1986) A clinicopathological study of 323 patients with oligodendrogliomas. Ann. Neurol. 19, 15-21.[CrossRef][Web of Science][Medline]

Macdonald, D.R., O'Brien, R.A., Gilbert, J.J., and Cairncross, J.G. (1989) Metastatic anaplastic oligodendroglioma. Neurology 39,1593 -1596.[Abstract/Free Full Text]

Macdonald, D.R., Gaspar, L.E., and Cairncross, J.G. (1990) Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann. Neurol. 27,573 -574.[CrossRef][Web of Science][Medline]

Maintz, D., Fiedler, K., Koopmann, J., Rollbrocker, B., Nechev, S., Lenartz, D., Stangl, A.P., Louis, D.N., Schramm, J., Wiestler, O.D., and von Deimling, A. (1997) Molecular genetic evidence for subtypes of oligoastrocytomas. J. Neuropathol. Exp. Neurol. 56,1098 -1104.[Web of Science][Medline]

Margain, D., Peretti-Viton, P., Perez-Castillo, A.M., Martini, P., and Salamon, G. (1991) Oligodendrogliomas. J. Neuroradiol. 18,153 -160.[Web of Science][Medline]

Mason, W.P., Krol, G.S., and DeAngelis, L.M. (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46,203 -207.[Abstract/Free Full Text]

Mørk, S.J., Lindegaard, K.-F., Halvorsen, T.B., Lehmann, E.H., Solgaard, T., Hatlevoll, R., Harvei, S., and Ganz, J. (1985) Oligodendroglioma: Incidence and biological behavior in a defined population. J. Neurosurg. 63,881 -889.[Web of Science][Medline]

Nijjar, T.S., Simpson, W.J., Gadalla, T., and McCartney, M. (1993) Oligodendroglioma: The Princess Margaret Hospital experience (1958-1984). Cancer 71,4002 -4006.[CrossRef][Web of Science][Medline]

Nutt, C.L., Costello, J.F., Bambrick, L.L., Yarosh, D.B., Swinnen, L.J., Chambers, A.F., and Cairncross, J.G. (1995) O6-methyguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage. Can. J. Neurol. Sci. 22,111 -115.[Web of Science][Medline]

Pagni, C.A., Canavero, S., and Gaidolfi, E. (1991) Intramedullary "holocord" oligodendroglioma: Case report. Acta. Neurochir. 113,96 -99.

Paleologos, N.A., Zemrus, T., Allen, C.V., Ragin, A., Walsh, A., Lapin, G.D., Groothuis, D.R., and Vick, N.A. (1992) Oligodendrogliomas: CT measurement of transcapillary permeability and response to vincristine chemotherapy. Ann. Neuro. 23, 289. (Abstract)

Paleologos, N., MacDonlad, D., and Vick, N. (1995) Neoadjuvant (pre-radiation [RT]) procarbazine, CCNU and vincristine (PCV) for anaplastic oligodendroglioma (AO) and aggressive oligodendroglioma (AgO). Neurology 45 (Suppl. 4),A387 . (Abstract)

Paleologos, N.A., Vick, N.A., and Kachoris, J.P. (1994) Chemotherapy for low-grade oligodendrogliomas? Ann. Neurol. 36,294 -295. (Abstract)

Peterson, K., Paleologos, N., Forsyth, P., Macdonald, D.R., and Cairncross, J.G. (1996) Salvage chemotherapy for oligodendroglioma. J. Neurosurg. 85,597 -601.[Web of Science][Medline]

Reedy, D.P., Bay, J.W., and Hahn, J.F. (1983) Role of radiation therapy in the treatment of cerebral oligodendroglioma: An analysis of 57 cases and a literature review. Neurosurgery 13,499 -503.[Web of Science][Medline]

Reifenberger, J., Reifenberger, G., Liu, L., James, C.D., Wechsler, W., and Collins, V.P.S (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol. 145,1175 -1190.[Abstract]

Roosen, N., De La Porte, C., Van Vyve, M., Solheid, C., and Selosse, P. (1984) Familial oligodendroglioma: Case report. J. Neurosurg. 60,848 -849.[Web of Science][Medline]

Roelvink, N.C.A., Kamphorst, W., Lindhout, D., and Ponssen, H. (1986) Concordant cerebral oligodendroglioma in identical twins J. Neurol. Neurosurg. Psychiatry 49,706 -708.[Abstract/Free Full Text]

Rogers, L.R., Estes, M.L., Rosenbloom, S.A., and Harrold, L. (1995) Primary leptomeningeal oligodendroglioma: Case report. Neurosurgery 36,166 -169.[Web of Science][Medline]

Russell, D.S., and Rubinstein, J.J. (1989)Pathology of Tumors of the Nervous System. Fifth edition . Baltimore: Williams and Wilkins.

Saarinen, U.M., Pihko, H., and Makipernaa, A. (1990) High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: A case report. J. Neurooncol. 9, 57-61.[CrossRef][Medline]

Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., Tazelaar, H.D., and Davis, D.H. (1992) Oligodendrogliomas: The Mayo Clinic experience. J. Neurosurg. 76,428 -434.[Web of Science][Medline]

Shaw, E.G., Scheithauer, B.W., O'Fallon, J.R., and Davis, D.H. (1994) Mixed oligoastrocytomas: A survival and prognostic factor analysis. Neurosurgery 34,577 -582.[Web of Science][Medline]

Shimizu, K.T., Tran, L.M., Mark, R.J., and Selch, M.T. (1993) Management of oligodendrogliomas. Radiology 186,569 -572.[Abstract/Free Full Text]

Smith, M.T., Ludwig, C.L., Godfrey, A.D., and Armbrustmacher, V.W. (1983) Grading of oligodendrogliomas. Cancer 52,2107 -2114.[CrossRef][Web of Science][Medline]

Soffietti, R., Chio, A., Mocellini, C., Rudà, R., Vigliani, M.C., Schiffer, D., Sciolla, R., Seliak, D. (1994) Response of oligodendroglial tumors to PCV chemotherapy. Neurology 44 (Suppl. 2),A309 -A310. (Abstract)

Soffietti, R., Chio, A., Mocellini, C., Rudà, R., Schiffer, D., Sciolla, R. (1995) Treatment with carboplatinum of oligodendroglial tumors recurrent after PCV chemotherapy. Neurology 45 (Suppl. 4),A261 . (Abstract)

Sun, Z.M., Genka, S., Shitara, N., Akanuma, A., and Takakura, K. (1988) Factors possibly in'uencing the prognosis of oligodendroglioma. Neurosurgery 22,886 -891.[Web of Science][Medline]

Vonofakos, D., Marcu, H., and Hacker, H. (1979) Oligodendrogliomas: CT patterns with emphasis on features indicating malignancy. J. Comp. Assist. Tomogr. 3, 783-788.[Web of Science][Medline]

Wallner, K.E., Gonzales, M., and Sheline, G.E. (1988) Treatment of oligodendrogliomas with or without postoperative irradiation. J. Neurosurg. 68,684 -688.[Web of Science][Medline]

Wiestler, O., Kleihues, P., and Pegg, A.E. (1984) O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis 5, 121-124.[Abstract/Free Full Text]

Wilkinson, I.M.S., Anderson, J.R., and Holmes, A.E. (1987) Oligodendroglioma: An analysis of 42 cases. J. Neurol. Neurosurg. Psychiatry 50,304 -312.[Abstract/Free Full Text]

Yuen, S.T., Fung, C.F., Ng, T.H., and Leung, S.Y. (1992) Central neurocytoma: its differentiation from intraventricular oligodendroglioma. Childs Nerv. Syst. 8, 383-388.[CrossRef][Web of Science][Medline]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
M. S. Nielsen, H. C. Christensen, M. Kosteljanetz, and C. Johansen
Incidence of and survival from oligodendroglioma in Denmark, 1943-2002
Neuro-oncol, January 1, 2009; 11(3): 311 - 317.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S. Sardell, D. Traish, A. Gonsalves, P. Wilkins, et al.
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
Ann. Onc., December 1, 2003; 14(12): 1715 - 1721.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Hong, A. W. Bollen, and J. F. Costello
The Contribution of Genetic and Epigenetic Mechanisms to Gene Silencing in Oligodendrogliomas
Cancer Res., November 15, 2003; 63(22): 7600 - 7605.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. E. McLendon, C. J. Wikstrand, M. R. Matthews, R. Al-Baradei, S. H. Bigner, and D. D. Bigner
Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor
J. Histochem. Cytochem., August 1, 2000; 48(8): 1103 - 1110.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. N. Fuller, C. H. Rhee, K. R. Hess, L. S. Caskey, R. Wang, J. M. Bruner, W. K. A. Yung, and W. Zhang
Reactivation of Insulin-like Growth Factor Binding Protein 2 Expression in Glioblastoma Multiforme: A Revelation by Parallel Gene Expression Profiling
Cancer Res., September 1, 1999; 59(17): 4228 - 4232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. H. Bigner, M. R. Matthews, B. K. A. Rasheed, R. N. Wiltshire, H. S. Friedman, A. H. Friedman, T. T. Stenzel, D. M. Dawes, R. E. McLendon, and D. D. Bigner
Molecular Genetic Aspects of Oligodendrogliomas Including Analysis by Comparative Genomic Hybridization
Am. J. Pathol., August 1, 1999; 155(2): 375 - 386.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paleologos, N. A.
Right arrow Articles by Cairncross, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 1999 by Society for Neuro-Oncology